ArticleCase reports in oncology
Excellent Response and Persistent Local Control of Metastatic Extraskeletal Myxoid Chondrosarcoma Repeatedly Treated with Surgical Excision or Stereotactic Radiotherapy Alone: A Case Report.
Article in Case reports in oncology. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
12 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Introduction: Extraskeletal myxoid chondrosarcoma (EMC) is an extremely rare mesenchymal tumor, accounting for less than 3% of soft tissue sarcomas. Even though metastatic rate after radical surgery in EMC can reach 50%, prolonged survival is common even in the presence of metastatic disease. Prospective studies evaluating the role of trabectedin, antiangiogenic agents, and immunotherapy are ongoing to assess the best systemic treatment. Case Presentation: We report the case of a young Sri Lankan woman who initially underwent neoadjuvant radiotherapy and surgery for a mass of the right thigh, then experienced local relapse, managed with chemotherapy and surgery again, and finally was diagnosed with distant progression. All metastatic sites of EMC were treated with either surgical excision or stereotactic ablative radiotherapy alone in three different occasions, showing complete or major response. Conclusion: This individualized approach enabled prolonged systemic therapy-free intervals with minimal toxicity, so could be considered in selected patients.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.